Alume Biosciences Inc.
San Diego, CA
- UEI
- MKDKYN7YB5D1
- CAGE
- 7XWP9
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 2223 Avenida De La Playa #205, La Jolla, CA 92037, USA
- Website
- alumebiosciences.com
- Founded
- 2017
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 38 Instruments & Related Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Similar vendors
About the company
Alume Biosciences Inc. is a biotechnology company that specializes in precision surgery. They provide a proprietary nerve illumination technology that helps surgeons visualize and preserve nerves during surgery. Alume has received multiple federal grants from the National Institutes of Health to support the development and commercialization of their lead drug candidate ALM-488 for nerve visualization during surgery.
The federal grants awarded to Alume Biosciences focus on advancing ALM-488 through clinical trials and toxicology studies towards FDA approval and commercialization. This includes a $937,219 project grant from the National Cancer Institute to fund clinical trials evaluating ALM-488 for improving nerve and ureter visualization during laparoscopic abdominal surgeries. Additionally, Alume received a $5 million project grant from the National Institute of Neurological Disorders and Stroke to enable manufacturing, stability, toxicology, and market assessment activities required for ALM-488's new drug application. Earlier project grants of $4.9 million and $300,000 from the NINDS also supported development of fluorescent probes like ALM-488 for highlighting nerves during image-guided surgeries. Through these awards, Alume aims to establish ALM-488 as a nerve contrast agent that prevents nerve damage and improves patient outcomes across a variety of surgeries.
Quick answers
Is Alume Biosciences Inc. registered in SAM.gov?
Yes. Alume Biosciences Inc.'s SAM.gov registration is active through January 26, 2027.
What is Alume Biosciences Inc.'s most recent federal award?
Alume Biosciences Inc.'s most recent federal grant award is Development of ALM-488 for nerve and ureter visualization during abdominal surgery (R44CA275546), from National Cancer Institute (NIH), on September 8, 2023.
On GovTribe
See Alume Biosciences Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors